The efficacy, safety and neonatal effects of oxycodone in treatment of labour pain

Status

Not yet recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516495-15-00

Enrollment

Registered

2024-08-09

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

labour

Brief summary

Oxycodone concentration in mater and umbilical cord at time of birth

Detailed description

Population pharmacocinetic model of oxycodone in parturient

Interventions

DRUGOxanest® 10 mg/ml -injektioneste

DRUGliuos

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
Oxycodone concentration in mater and umbilical cord at time of birth	—

Secondary

Measure	Time frame
Population pharmacocinetic model of oxycodone in parturient	—

Countries

Finland

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026